Close Menu
MyAppsPlus

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Apple Calendar got two feature upgrades it really needed in iOS 27

    November 20, 2026

    Ray-Ban Meta (Gen 2) glasses get $103 off for Black Friday

    November 20, 2026

    A transcription firm used by police, prosecutors and tech giants exposed customer data online

    November 20, 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    MyAppsPlusMyAppsPlus
    Friday, November 20
    • Home
    • Breaking Tech
    • Apps & Software
    • AI & Automation
    • Android
    • iPhone & iOS
    • More
      • Reviews
      • How-To Guides
      • Deals & Discounts
      • Shop
    MyAppsPlus
    Home»AI & Automation»How New Lab Automation Tools At Agilent Technologies (A) Have Changed Its Investment Story
    AI & Automation

    How New Lab Automation Tools At Agilent Technologies (A) Have Changed Its Investment Story

    myappsplusBy myappsplusOctober 5, 20260118 Mins Read
    Share Facebook Twitter Pinterest Copy Link LinkedIn Tumblr Email Telegram WhatsApp
    Follow Us
    Google News Flipboard
    How New Lab Automation Tools At Agilent Technologies (A) Have Changed Its Investment Story
    Share
    Facebook Twitter LinkedIn Pinterest Email Copy Link
    • Agilent Technologies has recently launched several lab automation and analysis products, including the NovoStation flow cytometry system, BioTek Gen5 AI cell identification module, and CE‑IVD TapeStationDx platforms for clinical NGS quality control.
    • These releases concentrate on reducing manual workload, improving data consistency, and supporting regulatory compliance. Together, these factors directly affect operating efficiency and long term demand for Agilent Technologies solutions.
    • This article examines how Agilent Technologies’ investment narrative may be influenced by its new NovoStation automation platform and related launches.

    Scan how Agilent Technologies’ push into lab automation compares with other laboratory technology plays by reviewing a curated set of 35 healthcare AI stocks. Advertisement

    Agilent Technologies Investment Narrative Recap

    For Agilent Technologies, the big picture to focus on is a lab tools supplier that can keep turning automation, services and diagnostics into steadier demand and better efficiency. The Ignite model, LC and GC replacement cycles and NASD capacity plans already frame that story. The recent automation launches and ICCS presence mainly reinforce this direction rather than reset it.

    The closest near-term catalyst remains execution on Ignite-driven margin gains while Train C ramps without eroding profitability. The biggest risk is still external pressure on research budgets and tariffs. The new products help operationally but do not materially change those macro sensitivities yet.

    The NovoStation Sample Preparation System looks most relevant here. It tightens Agilent Technologies integration across sample prep, instruments and software in flow cytometry. That aligns directly with the push toward higher recurring usage of its installed base, where automation that limits manual steps can make instruments more embedded in workflows and harder to displace.

    For catalysts, the key question is whether NovoStation and the Gen5 AI module deepen usage in pharma and clinical research where replacement cycles and CrossLab-style service revenues matter most. Execution risk lies in scaling these platforms across regions and customer types while maintaining validation quality and regulatory compliance, especially as TapeStationDx adoption increases in regulated labs.

    Agilent Technologies Forecasts Behind the Automation Story

    Analysts tie Agilent Technologies’ lab automation push into a broader set of numbers. They assume revenue grows by 7.0% each year over the next 3 years while profit margins move from 19.5% today to 24.9% in the same period. On their estimates, earnings today of about US$1.4b rise to a consensus of US$2.2b by 2029, which is an increase of roughly US$0.8b, with the more cautious forecasts closer to US$2.0b. That framework underpins a 2029 view of roughly US$9.0b of revenue and US$2.2b of profit.

    Agilent Technologies’ narrative projects US$9.0b revenue and US$2.2b earnings by 2029. This assumes 7.0% yearly revenue growth and about US$0.8b earnings increase from US$1.4b today.

    Those earnings assumptions link directly to the P/E math investors are being asked to accept. The analysts’ price targets rely on the business trading on about 27.4x those 2029 earnings, down from roughly 32.8x today and below the cited US Life Sciences sector level of 41.0x. In practice, that means the story needs both higher profit dollars and a lower earnings multiple to line up with the current fair value arguments.

    The current set of forecasts does not hard code the NovoStation or TapeStationDx launches into separate line items. Instead, they sit inside that 7.0% annual revenue growth assumption and the move toward a 24.9% margin profile. For an investor, the question is whether automation and AI driven products genuinely help the company reach those numbers by lifting throughput, pushing more recurring consumables and services, and keeping customer churn low.

    On the share side, analysts expect the number of shares outstanding to edge down by roughly 0.55% a year over the next 3 years. That type of gradual shrink in the share count can support earnings per share even if profit grows at a steadier rate, but it still relies on cash generation that matches buyback ambitions.

    These model assumptions all rest on a discount rate of about 8.2% to 8.24%. That rate is used to translate the 2029 revenue and earnings forecasts back into today’s value, which helps explain why small movements in growth, margin or the assumed P/E can shift the implied fair value more than the simple 4.2% gap between the US$167.78 share price and the US$175.2 consensus target might suggest.

    Uncover why Agilent Technologies’ fair value indicates a 4% potential upside to its current price that could narrow quickly.

    NYSE:A 1-Year Stock Price Chart
    NYSE:A 1-Year Stock Price Chart

    Exploring Other Perspectives

    Four fair value views from the Simply Wall St Community span roughly US$150 to US$189, with some retail investors seeing Agilent Technologies as heavily discounted while others lean toward a richer profile. Set that against risks around tariffs, academic funding strain and NASD ramp execution, then weigh how differently market participants can read the same automation story.

    Explore 3 other Agilent Technologies fair value estimates, including one that suggests as much as 13% upside from the current price.

    Decide For Yourself

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    • A great starting point for your Agilent Technologies research is our analysis highlighting 3 key rewards that could impact your investment decision.
    • See our latest analysis for Agilent Technologies. The report includes a comprehensive fundamental analysis summarized in a single visual, the Snowflake, making it easy to evaluate Agilent Technologies’ overall financial health at a glance.

    Looking For More Investment Ideas Beyond Agilent Technologies?

    If Agilent Technologies has sharpened your interest in tools, diagnostics and automation, it can be useful to compare it with other businesses that share similar financial strengths or income profiles. The Simply Wall St Screener gives you a way to filter by balance sheet quality, valuation, or income focus so you can build a watchlist that fits your own style.

    • If you care most about valuation support and financial resilience, start with a curated 31 high quality undervalued stocks that already combine solid fundamentals with attractive pricing.
    • If balance sheet strength is your anchor, filter for companies with low leverage and robust liquidity using the list of solid balance sheet and fundamentals (25 results).
    • If you want to broaden the opportunity set beyond widely followed tickers, scan through a focused group of 19 high quality undiscovered gems that still show strong underlying metrics.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data
    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.
    It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
    Simply Wall St has no position in any stocks mentioned.

    New:Manage All Your Stock Portfolios in One Place

    We’ve created the ultimate portfolio companion for stock investors, and it’s free.

    • Connect an unlimited number of Portfolios and see your total in one currency
    • Be alerted to new Warning Signs or Risks

    Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com

    Micron’s whole debate rests on one number. How many years are in a cycle?

    Not all cycles have the same length. In my view market is pricing this fairly now. It can 2x from here, if the demand and margin persists for a couple of years. AI capex won’t be endless.

    85 percent margin is an anomaly. The multiples we speak with are not very meaningful.

    mitchell_lawler
    Market Insights

    AI agents are redrawing competitive moats

    An AI agent compares every option, every time, and switches without a second thought. For the businesses that relied on you not having the time to check, the moat just moved.
    21
    Oct 2, 2026

    About NYSE:A

    Agilent Technologies

    Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

    Flawless balance sheet with solid track record.

    Similar Companies

    Market Insights

    AI agents are redrawing competitive moatsMI
    mitchell_lawler
    Where to invest when populations stop growingAL
    Alegget
    What happens to energy stocks as the fix gets built?MI
    mitchell_lawler
    Advertisement

    Weekly Picks

    BUFF logo

    Ceazaron Buffalo Potash·13 days ago

    Under the radar: This $78M stock controls a $1.5B project and it’ll start producing in a few months

    Fair Value:CA$1.0610.4% undervalued
    63followersusers have followed this narrative
    ·2commentsusers have commented on this narrative
    ·14likesusers have liked this narrative
    HE

    CRM logo

    HedgeYon Salesforce·26 days ago

    Salesforce: From Selling Seats to Selling Governed Work

    Fair Value:US$294.9320.4% undervalued
    19followersusers have followed this narrative
    ·0commentsusers have commented on this narrative
    ·5likesusers have liked this narrative
    IS

    ALAB logo

    isidrohgon Astera Labs·24 days ago

    Astera Labs Owns The Bottleneck That Isn’t Physical

    VNOM logo

    John_Ericon Viper Energy·17 days ago

    Everyone Else Drills the Wells. Viper Just Collects the Checks.

    RecentlyUpdated Narratives

    WM logo

    RockeTelleron Wallbridge Mining·about 13 hours ago

    Agnico, Waratah and Sprott Own Half. The Market Cap Is Still ~C$174M. That’s the Setup.

    BESI logo

    Ivoedon BE Semiconductor Industries·about 16 hours ago

    BESI’s AI Growth Is Becoming Real, But The Valuation Leaves Little Room For Error

    MA logo

    Estebanon Mastercard·about 20 hours ago

    Capital-light, high-return payment network that is successfully expanding into high-margin security and data services faster than its peers.

    Popular Narratives

    NVDA logo

    AnalystConsensusTargeton NVIDIA·4 days ago

    NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

    Fair Value:US$327.728.6% undervalued
    1553followersusers have followed this narrative
    ·8commentsusers have commented on this narrative
    ·36likesusers have liked this narrative
    AN

    GOOGL logo

    AnalystConsensusTargeton Alphabet·10 days ago

    AI Demand Must Outrun Infrastructure Buildout

    MSFT logo

    AnalystConsensusTargeton Microsoft·1 day ago

    Agilent Automation have Technologies tools
    Follow on Google News Follow on Flipboard
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Copy Link
    myappsplus
    • Website

    Related Posts

    Announcing AI data preparation capabilities in Amazon SageMaker: Build high-quality datasets for model development workflows

    November 20, 2026

    Factory AI that tunes machines works best with limits on what it can change

    November 20, 2026

    3 AI Infrastructure Stocks For Data Center And Automation Growth

    November 20, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    UiPath Launches AI Coding Agent, Integrates Claude Code and Codex to Target Development Automation

    November 16, 202644 Views

    The pros and cons of using your phone as a mobile hotspot

    November 16, 202642 Views

    Save on your groceries, gas, and holiday shopping with this $15 BJ’s membership (Reg. $60) 

    November 4, 202633 Views
    Latest Reviews

    Google has removed the Pixel Tablet from its store

    myappsplusSeptember 10, 2026

    Have hot and ready meals anywhere with East Oak’s 1.3L cordless heated lunch box at a new $54 low ($29 off)

    myappsplusSeptember 10, 2026

    Everything you need to know about pre-ordering the iPhone Duo and the iPhone 18 Pro in Australia

    myappsplusSeptember 10, 2026
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram

    Subscribe to Updates

    Get the latest tech news from FooBar about tech, design and biz.

    Most Popular

    Bring the 8-in-1 space-saving Ninja Flip oven combo to your kitchen or dorm at $150 2026 low, more from $80

    September 10, 20260 Views

    The Roomba Duo is a floor-cleaning behemoth that can pull a tiny robovac from its hat — and it’s iRobot’s attempt at rejecting the ‘spec wars’ and trying ‘something different, something new’

    September 10, 20260 Views

    Gartner thinks these four trends will shape the future of work — so what will they mean for you?

    September 10, 20260 Views
    Our Picks

    Apple Calendar got two feature upgrades it really needed in iOS 27

    November 20, 2026

    Ray-Ban Meta (Gen 2) glasses get $103 off for Black Friday

    November 20, 2026

    A transcription firm used by police, prosecutors and tech giants exposed customer data online

    November 20, 2026

    Subscribe to Updates

    Subscribe to our newsletter and get the latest tech news, app updates, AI trends, smartphone reviews, and exclusive deals delivered straight to your inbox.

    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Get In Touch
    • Disclaimer
    • Privacy Policy
    • Terms & Conditions
    © 2026 MyAppsPlus. All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.